Screening for genital chlamydia infection

Screening for genital chlamydia infection

BACKGROUND Genital infections caused by Chlamydia trachomatis are the most prevalent bacterial sexually transmitted infection worldwide. Screening of sexually active young adults to detect and treat asymptomatic infections might reduce chlamydia transmission and prevent reproductive tract morbidity, particularly pelvic inflammatory disease (PID) in women, which can cause tubal infertility and e...

Cultural method for large-scale screening for Chlamydia trachomatis genital infection.

Idoxuridine-treated McCoy cells grown as monolayers in 96 well microplates provide a convenient method for the isolation of Chlamydia trachomatis. Staining of infected monolayers with periodic acid-Schiff reagent (PAS) allows easy recognition of C trachomatis inclusions without the need for dark-ground microscopy. By this method 384 clinical specimens can be examined concurrently. It is suffici...

Protection against Genital Chlamydia trachomatis Infection

Review on Genital Chlamydia Trachomatis Infection

Correspondence address: Dr. K. H. Mak Yau Ma Tei Female Social Hygiene Clinic 3/F Yau Ma Tei Jockey Club Polyclinic 145 Battery Street, Yau Ma Tei Hong Kong ABSTRACT Chlamydia trachomatis infection is a common sexually transmitted disease worldwide. The genital infection can result in serious complications and sequelae such as infertility and ectopic pregnancy. However, early identification of ...

The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia.

BACKGROUND In Australia, there is no published study on the cost effectiveness of screening for chlamydia. The aim of this study was to examine the cost effectiveness of a hypothetical screening programme for chlamydia based on annual opportunistic testing of all women 25 years of age or younger consulting a general practitioner, compared with no screening. METHODS A decision-analytic modelli...